Verséa Biologics Division, headed by Dr. Sunil J. Panchal, M.D., Ph.D., Chief Scientific Officer, is focused on using the latest cutting-edge scientific advancements in regenerative medicine to provide novel treatment solutions that are fully compliant with the new FDA HCT regulations and use the progenerative power of amnion to help solve wound care, ocular care, and pain management problems.

The portfolio provides reimbursable healthcare options (Medicare & BCBS).